Group of Cell Therapy and Tissue Engineering Group, Research Institute on Health Sciences (IUNICS), University of the Balearic Islands, 07122, Palma, Spain.
Balearic Islands Health Research Institute (IdISBa), 07010, Palma, Spain.
J Mater Sci Mater Med. 2018 Jun 28;29(7):103. doi: 10.1007/s10856-018-6115-8.
Osteoinductive capacity of demineralized bone matrix (DBM) is sometimes insufficient or shows high variability between different batches of DBM. Here, we tried to improve its osteoinductive activity by alkali-urea or trypsin treatment but this strategy was unsuccessful. Then, we tested the enrichment of DBM with a bone protein extract (BPE) containing osteogenic growth factors comparing two sources: cortical bone powder and DBM. The osteoinductive capacity (alkaline phosphatase activity) of the obtained BPEs was evaluated in vitro in C2C12 cells. Specific protein levels present in the different BPE was determined by enzyme-linked immunosorbent assay or by a multiplex assay. BPE from cortical bone powder showed a lack of osteoinductive effect, in agreement with the low content on osteoinductive factors. In contrast, BPE from DBM showed osteoinductive activity but also high variability among donors. Thus, we decided to enrich DBM with BPE obtained from a pool of DBM from different donors. Following this strategy, we achieved increased osteoinductive activity and lower variability among donors. In conclusion, the use of a BPE obtained from a pool of demineralized bone to enrich DBM could be used to increase its osteoinductive effect and normalize the differences between donors.
脱矿骨基质(DBM)的成骨能力有时不足,或者在不同批次的 DBM 之间表现出高度的可变性。在这里,我们尝试通过碱-尿素或胰蛋白酶处理来提高其成骨活性,但该策略并未成功。然后,我们测试了用含有成骨生长因子的骨蛋白提取物(BPE)富集 DBM,比较了两种来源:皮质骨粉和 DBM。通过酶联免疫吸附试验或多重分析测定了体外 C2C12 细胞中获得的 BPE 的特定蛋白水平。皮质骨粉的 BPE 表现出缺乏成骨作用,这与成骨因子的低含量一致。相比之下,DBM 的 BPE 具有成骨活性,但不同供体之间也存在很大的可变性。因此,我们决定用从不同供体的 DBM 中提取的 BPE 来富集 DBM。通过这种策略,我们提高了成骨活性并降低了供体之间的变异性。总之,使用从脱矿骨中提取的 BPE 来富集 DBM,可以提高其成骨效果,并使供体之间的差异正常化。